Upgrade to SI Premium - Free Trial

Ovid Therapeutics Inc (OVID) PT Raised to $9 at Oppenheimer

August 3, 2026 8:35 AM
Oppenheimer analyst Jay Olson raised ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change